Personal Finance

Vericel : VCEL

VCEL

Stock Data

$44.20

$0.34 (0.76%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Vericel Corp, based in Cambridge, Massachusetts, specializes in advanced biopharmaceutical solutions, focusing on cellular therapies for sports medicine and severe burn care. The company offers innovative products like MACI, for knee cartilage repair, Epicel, a skin replacement for severe burns, and NexoBrid, designed for eschar removal in burn victims. Originally known as Aastrom Biosciences, Vericel leverages cutting-edge science to improve patient outcomes in North America.

Latest Activity

VCELVericel Corp

Q2 2026

Jul 30, 8:03am ET

EPS

$0.04

est -$0.03+$0.07

Revenue

$77M

est $73M+6.6%

Vericel swung to profitability with a 250% EPS beat and authorized its first $200 million share buyback, signaling confidence the cell therapy company has turned the corner on sustained growth. MACI cartilage repair notched a fifth straight quarter of 20%-plus revenue growth, now reaching $65.5 million, while free cash flow surged to $14.3 million from essentially flat a year ago.

ShareRead more

All Vericel Articles

0 Articles

No articles found for Vericel.